null

Pinatuzumab (Anti-CD22) Biosimilar Antibody

SKU:
HDBS0029
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD22
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
€373
Frequently bought together:

Description

system_update_altDatasheet

Pinatuzumab (Anti-CD22) Biosimilar Antibody (HDBS0029)

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) offered by Assay Genie is a cutting-edge monoclonal antibody designed for research purposes. This biosimilar MAb specifically targets CD22, a B-cell surface antigen that is highly expressed in B-cell malignancies. This antibody is produced using state-of-the-art biotechnology methods, ensuring high specificity and sensitivity in detecting CD22 in various samples. It is validated for use in techniques such as flow cytometry, immunohistochemistry, and immunoprecipitation, making it an invaluable tool for researchers studying B-cell related diseases like leukemia and lymphoma.

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) holds great promise in advancing our understanding of B-cell biology and developing targeted therapies for B-cell derived cancers. Its high affinity for CD22 and reliable performance in experimental settings make it a valuable asset for researchers seeking to uncover new insights into the mechanisms underlying these diseases.